{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:42:50Z","timestamp":1790638970093,"version":"4.1.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,9,12]]},"abstract":"\n Importance<\/jats:title>\n Recent reports have suggested that cerebral amyloid angiopathy, a common cause of multiple spontaneous intracerebral hemorrhages (ICHs), may be transmissible through parenteral injection of contaminated cadaveric pituitary hormone in humans.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether spontaneous ICH in blood donors after blood donation is associated with development of spontaneous ICH in transfusion recipients.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Exploratory retrospective cohort study using nationwide blood bank and health register data from Sweden (main cohort) and Denmark (validation cohort) and including all 1\u202f089\u202f370 patients aged 5 to 80 years recorded to have received a red blood cell transfusion from January 1, 1970 (Sweden), or January 1, 1980 (Denmark), until December 31, 2017.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Receipt of red blood cell transfusions from blood donors who subsequently developed (1) a single spontaneous ICH, (2) multiple spontaneous ICHs, or (3) no spontaneous ICH.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Spontaneous ICH in transfusion recipients; ischemic stroke was a negative control outcome.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 759\u202f858 patients from Sweden (median age, 65 [IQR, 48-73] years; 59% female) and 329\u202f512 from Denmark (median age, 64 [IQR, 50-73] years; 58% female) were included, with a median follow-up of 5.8 (IQR, 1.4-12.5) years and 6.1 (IQR, 1.5-11.6) years, respectively. Patients who underwent transfusion with red blood cell units from donors who developed multiple spontaneous ICHs had a significantly higher risk of a single spontaneous ICH themselves, compared with patients receiving transfusions from donors who did not develop spontaneous ICH, in both the Swedish cohort (unadjusted incidence rate [IR], 3.16 vs 1.12 per 1000 person-years; adjusted hazard ratio [HR], 2.73; 95% CI, 1.72-4.35;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and the Danish cohort (unadjusted IR, 2.82 vs 1.09 per 1000 person-years; adjusted HR, 2.32; 95% CI, 1.04-5.19;\n P<\/jats:italic>\n \u2009=\u2009.04). No significant difference was found for patients receiving transfusions from donors who developed a single spontaneous ICH in the Swedish cohort (unadjusted IR, 1.35 vs 1.12 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.84-1.36;\n P<\/jats:italic>\n \u2009=\u2009.62) nor the Danish cohort (unadjusted IR, 1.36 vs 1.09 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.70-1.60;\n P<\/jats:italic>\n \u2009=\u2009.73), nor for ischemic stroke as a negative control outcome.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In an exploratory analysis of patients who received red blood cell transfusions, patients who underwent transfusion with red blood cells from donors who later developed multiple spontaneous ICHs were at significantly increased risk of spontaneous ICH themselves. This may suggest a transfusion-transmissible agent associated with some types of spontaneous ICH, although the findings may be susceptible to selection bias and residual confounding, and further research is needed to investigate if transfusion transmission of cerebral amyloid angiopathy might explain this association.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2023.14445","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:02:30Z","timestamp":1694516550000},"page":"941","source":"Crossref","is-referenced-by-count":54,"title":["Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients"],"prefix":"10.1001","volume":"330","author":[{"given":"Jingcheng","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Rostgaard","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark"},{"name":"Danish Cancer Society Research Center, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Lauwers","sequence":"additional","affiliation":[{"name":"VIB Center for Brain and Disease Research, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Dahl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden"},{"name":"Hematology Department, Karolinska University Hospital, Stockholdm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Erikstrup","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Birger","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Immunology, Zealand University Hospital, K\u00f8ge, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Strooper","sequence":"additional","affiliation":[{"name":"VIB Center for Brain and Disease Research, Leuven, Belgium"},{"name":"Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium"},{"name":"Dementia Research Institute, University College London, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lemmens","sequence":"additional","affiliation":[{"name":"VIB Center for Brain and Disease Research, Leuven, Belgium"},{"name":"Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium"},{"name":"Department of Neurology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark"},{"name":"Danish Cancer Society Research Center, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Hematology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaf","family":"Edgren","sequence":"additional","affiliation":[{"name":"Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Cardiology, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"jpc230004r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","article-title":"Cerebral amyloid angiopathy: a systematic review.","volume":"7","author":"Biffi","year":"2011","journal-title":"J Clin Neurol"},{"issue":"8","key":"jpc230004r2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","article-title":"Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis.","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"jpc230004r3","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/STROKEAHA.112.661603","article-title":"SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage.","volume":"43","author":"Meretoja","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"jpc230004r4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/ene.v29.1","article-title":"SMASH-U aetiological classification: a predictor of long-term functional outcome after intracerebral haemorrhage.","volume":"29","author":"Jia","year":"2022","journal-title":"Eur J Neurol"},{"issue":"9","key":"jpc230004r5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1161\/STROKEAHA.114.005598","article-title":"Pathogenetical subtypes of recurrent intracerebral hemorrhage: designations by SMASH-U classification system.","volume":"45","author":"Yeh","year":"2014","journal-title":"Stroke"},{"issue":"7568","key":"jpc230004r6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u00df pathology and cerebral amyloid angiopathy.","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"issue":"7736","key":"jpc230004r7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-018-0790-y","article-title":"Transmission of amyloid-\u00df protein pathology from cadaveric pituitary growth hormone.","volume":"564","author":"Purro","year":"2018","journal-title":"Nature"},{"issue":"2","key":"jpc230004r8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-017-1703-0","article-title":"Amyloid-\u00df accumulation in the CNS in human growth hormone recipients in the UK.","volume":"134","author":"Ritchie","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"jpc230004r9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40478-017-0503-z","article-title":"Iatrogenic Creutzfeldt-Jakob disease with amyloid-\u00df pathology: an international study.","volume":"6","author":"Cali","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"jpc230004r10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00401-018-1822-2","article-title":"Evidence of amyloid-\u00df cerebral amyloid angiopathy transmission through neurosurgery.","volume":"135","author":"Jaunmuktane","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"5794","key":"jpc230004r11","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"issue":"6006","key":"jpc230004r12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied A\u00df-containing inoculates induce cerebral \u00df-amyloidosis.","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"issue":"1","key":"jpc230004r13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s40478-020-01087-1","article-title":"Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer\u2019s disease.","volume":"8","author":"Morales","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"jpc230004r14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40478-018-0511-7","article-title":"Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA).","volume":"6","author":"Burwinkel","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"jpc230004r15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt-Jakob disease, final assessment.","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"jpc230004r16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S1474-4422(20)30238-6","article-title":"Potential human transmission of amyloid \u00df pathology: surveillance and risks.","volume":"19","author":"Lauwers","year":"2020","journal-title":"Lancet Neurol"},{"issue":"12","key":"jpc230004r17","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1111\/trf.v60.12","article-title":"The Swedish Scandinavian Donations and Transfusions Database (SCANDAT3-S)\u201450?years of donor and recipient follow-up.","volume":"60","author":"Zhao","year":"2020","journal-title":"Transfusion"},{"issue":"7","key":"jpc230004r18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/trf.2015.55.issue-7","article-title":"The new Scandinavian Donations and Transfusions Database (SCANDAT2): a blood safety resource with added versatility.","volume":"55","author":"Edgren","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"jpc230004r19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7326\/M15-2421","article-title":"Transmission of neurodegenerative disorders through blood transfusion: a cohort study.","volume":"165","author":"Edgren","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"jpc230004r20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/joim.2018.284.issue-1","article-title":"Searching for unknown transfusion-transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients.","volume":"284","author":"Edgren","year":"2018","journal-title":"J Intern Med"},{"issue":"29","key":"jpc230004r21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2807\/1560-7917.ES.2020.25.29.1900537","article-title":"Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012.","volume":"25","author":"Dahl","year":"2020","journal-title":"Euro Surveill"},{"issue":"1","key":"jpc230004r22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/jcbfm.2015.88","article-title":"Ischemic brain injury in cerebral amyloid angiopathy.","volume":"36","author":"Reijmer","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"jpc230004r23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/vox.2009.96.issue-4","article-title":"Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma.","volume":"96","author":"Shanwell","year":"2009","journal-title":"Vox Sang"},{"issue":"11","key":"jpc230004r24","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1111\/trf.v60.11","article-title":"Patterns of blood use in Sweden from 2008 to 2017: a nationwide cohort study.","volume":"60","author":"Auvinen","year":"2020","journal-title":"Transfusion"},{"issue":"5","key":"jpc230004r25","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing E-values.","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"4","key":"jpc230004r26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"jpc230004r27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios.","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"jpc230004r28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-5573-5-7","article-title":"Methods for stratification of person-time and events\u2014a prerequisite for Poisson regression and SIR estimation.","volume":"5","author":"Rostgaard","year":"2008","journal-title":"Epidemiol Perspect Innov"},{"issue":"1","key":"jpc230004r31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease\u2014one peptide, two pathways.","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"jpc230004r32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/nan.v46.6","article-title":"The role of prion-like mechanisms in neurodegenerative diseases.","volume":"46","author":"Jaunmuktane","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"jpc230004r33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/jnnp-2022-328792","article-title":"Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon.","volume":"93","author":"Banerjee","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"jpc230004r34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fnmol.2019.00233","article-title":"A\u00df seeding as a tool to study cerebral amyloidosis and associated pathology.","volume":"12","author":"riesen","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"jpc230004r35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.v18.1","article-title":"Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis.","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"jpc230004r36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-020-00972-z","article-title":"Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage.","volume":"8","author":"J\u00e4kel","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"jpc230004r37","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/01.STR.30.8.1643","article-title":"Cerebral amyloid angiopathy-related hemorrhage: interaction of APOE e2 with putative clinical risk factors.","volume":"30","author":"McCarron","year":"1999","journal-title":"Stroke"},{"key":"jpc230004r29","volume-title":"STPM2: Stata Module To Estimate Flexible Parametric Survival Models","author":"Lambert","year":"2010"},{"key":"jpc230004r30","volume-title":"Marginal Estimates Through Regression Standardization in Competing Risks and Relative Survival Models","author":"Lambert","year":"2020"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2809417\/jama_zhao_2023_pc_230004_1694462887.56673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:02:34Z","timestamp":1694516554000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2809417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,9,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.14445","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742777573.793600939","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.742777573.793601139","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}